It is accepted within the cardiology community that measurements pertaining to absolute myocardial blood flow (MBF) and myocardial flow reserve (MFR) provide additional information about a patient’s heart condition than general perfusion. Researchers are still perfecting a standard procedure for obtaining these measurements, but they seem to be getting close in the case of dynamic SPECT, according to a study published Sept. 4 in the Journal of Nuclear Medicine.

BC Technical, a provider of used and refurbished radiological and molecular imaging equipment, has announced the West Jordan-based company’s acquisition of Polaris Medical Imaging, seller, servicer and installer of specifically GE MRI and CT scanners. BC also provides SPECT/CT, PET, PET/CT and other nuclear medicine systems.

The worldwide market for nuclear medicine was estimated at around $5.5 billion in 2013, but by 2020 that figure is expected to grow to $8.05 billion at an annual compound growth rate of 5.6 percent, according to a report by IQ41 Research And Consultancy.

The Centers for Medicare & Medicaid Services (CMS) has provided projected U.S. healthcare spending for the next several years and it is modest. Due to a timid economy and higher private insurance plan costs that pinch demand for healthcare services, average annual healthcare spending is expected to grow by 5.7 percent this year and just about 6 percent from 2013 to 2023.

Monona, Wis., company Shine Medical Technologies has closed on $2.4 million in financing from a range of sources as the makers of medical isotope production technology wait for a construction permit to move forward on a new U.S. facility, Shine announced Wednesday.

The use of dissolution dynamic nuclear polarization has led scientists to a technique called hyperpolarization, which allows them to see real-time metabolic activity and vastly improves MR signal of nuclei, according to a review published Aug. 28 in the Journal of Nuclear Medicine.

In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests.

The Wagner-Torizuka fellowship, created by Henry N. Wagner, Jr., MD, and Kanji Torizuka, MD, PhD, provides Japanese clinicians in the field of molecular imaging a major platform for advanced training and research. Three physicians have been honored with the fellowship, SNMMI announced yesterday.